Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular cells,...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Reticular Dermis01:15

Reticular Dermis

The papillary and reticular dermis are the two layers of the dermis. They are made of connective tissue with fibers of collagen extending from one to the other, making the border between the two somewhat indistinct. The dermal papillae extending into the epidermis belong to the papillary layer, whereas the dense collagen fiber bundles below belong to the reticular layer.
Reticular Layer
Underlying the papillary layer is the much thicker reticular layer, composed of dense, irregular connective...
Healing II: Complications01:24

Healing II: Complications

Complications during healing arise when tissue repair is altered by local or systemic factors. These changes involve abnormal collagen deposition, altered biomechanics, and reduced vascular supply, impairing restoration of normal structure and function.Loss of FunctionScar tissue differs significantly from the original tissue it replaces. In the skin, fibrosis lacks adnexal structures such as hair follicles, sebaceous glands, and sweat glands. Their absence reduces tactile sensitivity, impairs...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Mesothelioma location influences the tumour microenvironment and immune checkpoint therapy response in preclinical models.

Scientific reports·2026
Same author

Hidden Targets in Cancer Immunotherapy: The Potential of "Dark Matter" Neoantigens.

Vaccines·2026
Same author

Comparative analysis of malignant pleural effusion and peripheral blood reveals unique T cell signatures associated with survival in mesothelioma patients.

Oxford open immunology·2026
Same author

Coupling of response biomarkers between tumor and peripheral blood in patients undergoing chemoimmunotherapy.

Cell reports. Medicine·2024
Same author

Mesothelioma survival prediction based on a six-gene transcriptomic signature.

iScience·2024
Same author

Trends in smoking initiation and cessation over a century in two Australian cohorts.

PloS one·2024
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Jul 16, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

El mesotelioma maligno es un mesotelioma maligno.

Bruce W S Robinson1, Arthur W Musk, Richard A Lake

  • 1Tumour Immunology Group, School of Medicine and Pharmacology, University of Western Australia, Australia. bwsrobin@cyllene.uwa.edu.au

Lancet (London, England)
|August 2, 2005
PubMed
Resumen

El mesotelioma maligno es un cáncer agresivo vinculado al amianto y potencialmente al virus simio 40 (SV40). Su patología molecular implica la pérdida de genes supresores de tumores específicos, ayudando al diagnóstico y al pronóstico.

Más Videos Relacionados

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Videos de Experimentos Relacionados

Last Updated: Jul 16, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Área de la Ciencia:

  • Oncología Oncología.
  • Patología Patología Patología.
  • Virología Virología.

Sus antecedentes:

  • El mesotelioma maligno es un cáncer agresivo, cada vez más frecuente.
  • La exposición al amianto es el principal factor de riesgo, con el virus simio 40 (SV40) como un posible contribuyente.
  • La enfermedad presenta síntomas como dificultad para respirar y dolor en el pecho, a menudo con derrames pleurales.

Objetivo del estudio:

  • Resumir los aspectos clave del mesotelioma maligno, incluida su etiología, patología, diagnóstico y estrategias de tratamiento actuales.
  • Para resaltar las características moleculares únicas del mesotelioma.
  • Discutir el papel potencial de las nuevas herramientas de diagnóstico y pronóstico.

Principales métodos:

  • Revisión de la literatura actual sobre el mesotelioma maligno.
  • Análisis de los criterios de diagnóstico citopatológicos e histopatológicos.
  • Examen de la patología molecular, centrándose en las alteraciones del gen supresor de tumores.
  • Consideración de los hallazgos del estudio de microarrays para el diagnóstico y el pronóstico.

Principales resultados:

  • El mesotelioma exhibe una patología molecular distinta, caracterizada por la pérdida de los genes supresores de tumores P16INK4A, P14ARF y NF2.
  • La citopatología y la histopatología son cruciales para el diagnóstico.
  • La supervivencia media es de aproximadamente 12 meses después del diagnóstico.
  • La quimioterapia paliativa beneficia a los pacientes con buen estado de rendimiento.

Conclusiones:

  • El mesotelioma maligno requiere un enfoque de diagnóstico multifacético.
  • Comprender su perfil molecular único es clave para el diagnóstico y el pronóstico.
  • Se justifica una mayor investigación sobre la terapia génica, la inmunoterapia y los patrones de microarrays.